1,296 results on '"Finlay M"'
Search Results
52. Mantle volatiles and heat contributions in high sulfidation epithermal deposit from the Zijinshan Cu-Au-Mo-Ag orefield, Fujian Province, China: Evidence from He and Ar isotopes
53. Evidence for multiple Plio-Pleistocene lake episodes in the hyperarid Atacama Desert
54. Impact of attributed audit on procedural performance in cardiac electrophysiology catheter laboratory
55. Constraints on the Miocene landscape evolution of the Eastern Alps from the Kalkspitze region, Niedere Tauern (Austria)
56. Rapid exhumation of young granites in an extensional domain: the example of the Giglio Island pluton (Tuscany)
57. Correction to “Discovery of a Thiadiazole–Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models”
58. Genesis of the Jinding Zn-Pb deposit, northwest Yunnan Province, China: Constraints from rare earth elements and noble gas isotopes
59. A propensity matched case–control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator
60. Constant 4He Concentration and 190Pt‐4He age of Detrital Pt‐Alloy Grains from the Santiago River, Ecuador: Potential as a 4He Mineral Reference Material.
61. Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same
62. The performance of the Noblesse multi-collector noble gas mass spectrometer for 40Ar/39Ar geochronology
63. The use of in-situ cosmogenic 21Ne in studies on long-term landscape development
64. Constant4 HeConcentration and190 Pt‐ 4 Heage of Detrital Pt‐Alloy Grains from the Santiago River, Ecuador: Potential as a4 HeMineral Reference Material
65. Supplementary Figure 1 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
66. Supplementary Table 1 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
67. Supplementary Figure 3 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
68. Supplementary Figure 4 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
69. Supplementary Figure 5 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
70. Supplementary Figure 2 from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
71. Data from Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
72. Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners
73. Supplementary Figure 3 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
74. Data from Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions
75. Supplementary Table 1 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
76. Supplementary Figure 1 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
77. Supplementary Figures 1-8 from Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions
78. Supplementary Figure 7 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
79. Supplementary Figure 4 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
80. Supplementary Figure 5 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
81. Supplementary Figure 6 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
82. Supplementary Figure 2 from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
83. Data from AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
84. Supplementary Data from Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs
85. Figure S1 from Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs
86. A topographic hinge-zone divides coastal and inland ice dynamic regimes in East Antarctica
87. Epicardial catheter ablation for ventricular tachycardia on uninterrupted warfarin: A safe approach for those with a strong indication for peri-procedural anticoagulation?
88. The total synthesis of the bicyclic acetal core of zaragozic acid C
89. The Winchcombe meteorite, a unique and pristine witness from the outer solar system
90. Small Molecule Inhibitors of the Epidermal Growth Factor Receptor
91. Dispersion aspects of periodically amplified soliton transmission systems
92. AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity
93. Adrenal tumours in patients with pathogenic APC mutations: a retrospective study
94. A two phase escarpment evolution of the Red Sea margin of southwestern Saudi Arabia. Insights from low-temperature apatite thermochronology
95. Multi-Isotope Geochemical Baseline Study of the Carbon Management Canada Research Institutes CCS Field Research Station (Alberta, Canada), Prior to CO2 Injection
96. Intensive Chemical Weathering in the Arctic During the Miocene Climatic Optimum
97. Tracing injected CO2 in the Cranfield enhanced oil recovery field (MS, USA) using He, Ne and Ar isotopes
98. Interlaboratory comparison of cosmogenic 21Ne in quartz
99. ARC Genotype Modulates Slow Wave Sleep and EEG Spectral Power Following Total Sleep Deprivation
100. Impact of CaSO
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.